ライフサイエンスコーパス: cancer prevention

1 plays a critical role in cellular stress and cancer prevention.

2 2 has been suggested to offer a strategy for cancer prevention.

3 yanins in P40 may provide extra benefits for cancer prevention.

4 re and perhaps extraordinary opportunity for cancer prevention.

5 ion with direct therapeutic implications for cancer prevention.

6 to determine the optimal use of aspirin for cancer prevention.

7 benefit-to-harm ratio of the drug for breast cancer prevention.

8 iruses (gammaHVs) is an important target for cancer prevention.

9 hallenge and an enormous opportunity in skin cancer prevention.

10 or our understanding of cancer causation and cancer prevention.

11 al and human intervention studies on tea and cancer prevention.

12 d to development of anticancer therapies and cancer prevention.

13 to assess the possible role of vitamin D in cancer prevention.

14 atase inhibitors to antiestrogens for breast cancer prevention.

15 ave transformed the practice of oncology and cancer prevention.

16 ould be an important strategy for pancreatic cancer prevention.

17 edback loop may be an important strategy for cancer prevention.

18 therapy may offer some therapeutic value in cancer prevention.

19 aped curve for micronutrients in relation to cancer prevention.

20 reening tests that offer the opportunity for cancer prevention.

21 types have the potential to improve cervical cancer prevention.

22 rly, sustained ART is a crucial component of cancer prevention.

23 odel of breast cancer, with implications for cancer prevention.

24 entially can play an important role in colon cancer prevention.

25 ing such alterations, therefore, may lead to cancer prevention.

26 and provides novel insights into its role in cancer prevention.

27 signaling pathway may be important in breast cancer prevention.

28 is kinase is a relevant strategy for mammary cancer prevention.

29 ess costly, are keys to continued success in cancer prevention.

30 nable to pharmacologic manipulation for skin cancer prevention.

31 re to alcohol has important implications for cancer prevention.

32 Sun-protective behavior affects skin cancer prevention.

33 functional foods or nutraceuticals for colon cancer prevention.

34 itamin D supplementation is useful in breast cancer prevention.

35 umor initiation, which is highly relevant to cancer prevention.

36 sed on nfGNPs for HPV detection and cervical cancer prevention.

37 ategy, namely, reverse-engineering precision cancer prevention.

38 r guiding public health strategies of breast cancer prevention.

39 that arise, and novel strategies for ovarian cancer prevention.

40 role of dietary selenium (Se) in colorectal cancer prevention.

41 issues from various types of insults and for cancer prevention.

42 g both YAP and AKT in liver size control and cancer prevention.

43 potential to save millions of lives through cancer prevention.

44 garding all things cancer related, including cancer prevention.

45 rivate practice would have a career focus in cancer prevention.

46 crobiome in breast carcinogenesis and breast cancer prevention.

47 mplementation of policies to improve primary cancer prevention.

48 Selenium, a potential cancer prevention agent currently being tested against p

49 ly undergoing clinical evaluation as a novel cancer prevention agent.

50 thus functions as an important regulator of cancer prevention and aging.

51 Thus, retinoid research benefits both cancer prevention and cancer treatment.

52 Despite the huge potential importance of cancer prevention and clinical success stories such as t

53 r risk, and evaluate the potential impact of cancer prevention and control strategies on cancer rates

54 y serve as potential therapeutic targets for cancer prevention and control.

55 We conclude that colorectal cancer prevention and dysplasia management for patients

56 ly important questions that are critical for cancer prevention and early detection in women carrying

57 otocol-0199 (GOG-0199), the National Ovarian Cancer Prevention and Early Detection Study.

58 ith HIV/AIDS (PLWHA) highlights the need for cancer prevention and early detection.

59 Objective: To characterize skin cancer prevention and education needs in uninsured, mino

60 In 2014, the Cancer Prevention and Ethics Committees of ASCO commissi

61 Cancer prevention and health promotion are also in the r

62 dence-informed frameworks for cost-effective cancer prevention and management are essential for deliv

63 ouraging exercise fitness in the clinics for cancer prevention and may promote the development of new

64 a possible molecular basis for zinc-induced cancer prevention and Orai1-SOCE signaling pathway in ca

65 ety of health care and research settings for cancer prevention and pharmacology research.

66 ies investigating the effects of exercise in cancer prevention and progression.

67 Pharmacyclics Inc, Cancer Prevention and Research Institute of Texas, Leuke

68 Cancer Prevention and Research Institution of Texas and

69 Interest in prostate cancer prevention and risk reduction continues among bot

70 Additional efforts aimed at cancer prevention and screening in people with HIV are w

71 genesis, underscoring the potential for lung cancer prevention and screening.

72 gnize the potential of obesity management in cancer prevention and that excess body weight in women i

73 Cancer prevention and the creation of a culture of healt

74 In May 2016, the Division of Cancer Prevention and the Division of Cancer Control and

75 ves and analogues and their potential use in cancer prevention and therapy, which are related to thei

76 malignant progression, with implications for cancer prevention and therapy.

77 agonists with minimal side effects for colon cancer prevention and therapy.

78 might therefore be an attractive option for cancer prevention and therapy.

79 eful approach for applying luteolin for lung cancer prevention and therapy.

80 progression with important implications for cancer prevention and therapy.

81 d D3 might be a suitable strategy for breast cancer prevention and therapy.

82 y as a whole, has implications for effective cancer prevention and therapy.

83 r developing a "pro-senescence" approach for cancer prevention and therapy.

84 ing that CD44 may be an important target for cancer prevention and therapy.

85 of Skp2 may represent a general approach for cancer prevention and therapy.

86 naling loop could be a new approach for lung cancer prevention and therapy.

87 SP expression may offer new targets for skin cancer prevention and therapy.

88 ning frequency and behaviors related to skin cancer prevention and to investigate whether these assoc

89 ning frequency and behaviors related to skin cancer prevention and to investigate whether these assoc

90 nvestigating how ASCO might favorably affect cancer prevention and treatment in resource-poor countri

91 3 into wild-type p53 have been suggested for cancer prevention and treatment, but they face a variety

92 Metformin has utility in cancer prevention and treatment, though the mechanisms f

93 een metformin use and a beneficial effect on cancer prevention and treatment, which has led to increa

94 n "the race" and its consequences for breast cancer prevention and treatment.

95 tigated extensively for its effective use in cancer prevention and treatment.

96 ose that a CCR5 antagonist can serve for HCC cancer prevention and treatment.

97 ins offer exceptional promise in the area of cancer prevention and treatment.

98 F2 might be a potential molecular target for cancer prevention and treatment.

99 respiration is a promising novel avenue for cancer prevention and treatment.

100 ld be valuable to the patient and family for cancer prevention and treatment.

101 tes to cancer etiology is important for both cancer prevention and treatment.

102 a potential target for premenopausal breast cancer prevention and treatment.

103 udies on metformin and related biguanides in cancer prevention and treatment.

104 ical suppression, a potential future mode of cancer prevention and treatment.

105 s an effective therapeutic avenue for breast cancer prevention and treatment.

106 est a role of VentX as a potential target in cancer prevention and treatment.

107 may provide unique effective strategies for cancer prevention and treatment.

108 for exploring the NAMPT pathway for prostate cancer prevention and treatment.

109 CC), the inhibition of which is explored for cancer prevention and treatment.

110 lity may be a potential agent for pancreatic cancer prevention and treatment.

111 dentified pathways may be valuable for colon cancer prevention and treatment.

112 g p38gamma may be a novel strategy for colon cancer prevention and treatment.

113 omized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines f

114 rtance of sun protection and facilitate skin cancer prevention and, therefore, decrease the skin canc

115 interest in possible roles of biguanides in cancer prevention and/or treatment.

116 hat it is particularly promising for bladder cancer prevention and/or treatment.

117 the most investigated selenium compounds in cancer-prevention and -therapy.

118 ffects of anti-oestrogen treatment in breast cancer prevention, and suggest that fibroblast growth fa

119 n to cancer risk, discusses implications for cancer prevention, and suggests future research directio

120 t few years, with improvements in screening, cancer prevention, and treatment, and is best defined fo

121 owever, data on the risk-benefit profile for cancer prevention are insufficient and no definitive rec

122 More studies of aspirin and cancer prevention are needed to define the lowest effect

123 s, reports on FGFR inhibitor-mediated breast cancer prevention are sparse.

124 indicated they would likely be interested in cancer prevention as a career focus, although only 12% t

125 of men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study and the Prostate, Lung, C

126 the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.

127 ments in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.

128 serum in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.

129 have drawn a great deal of attention toward cancer prevention because of their wide safety margin.

130 Among patient factors related to cancer prevention behaviors, patients' stated behavioral

131 netically engineered mouse models but weaker cancer prevention benefit in chemically induced rat mode

132 ty would have been an effective strategy for cancer prevention, but the reality is that worldwide obe

133 health information, including advice on skin cancer prevention, but their effectiveness may be affect

134 ajor role in regulating genome stability and cancer prevention by controlling the key proteins involv

135 ty reduction with early cancer detection and cancer prevention by detection and removal of cancer pre

136 ns unclear whether MSA exerts its effects on cancer prevention by influencing angiogenesis within Se

137 ogen detoxification-independent mechanism of cancer prevention by ITCs has been attributed at least i

138 se findings suggest opportunities for breast cancer prevention by modifying individual estrogen metab

139 a driver for p53 mutagenesis and a guide for cancer prevention by NSAID treatment.

140 3 mutations in specific types of tumors, and cancer prevention by regular usage of NSAIDs.

141 gy will undoubtedly continue contributing to cancer prevention by using traditional epidemiologic stu

142 co Cessation and Control Subcommittee of the Cancer Prevention Committee (CaPC).

143 The Cancer Prevention Committee of the American Society of C

144 al trials of supplemental micronutrients for cancer prevention completed over the past 20 years, incl

145 Colon cancer prevention currently relies on colonoscopy using

146 burden of cancer, societal attitudes towards cancer prevention, effects of inequitable treatment and

147 ctal cancer, at least in men, and colorectal cancer prevention efforts should encourage the achieveme

148 Most addressed issues of cancer prevention, followed by diagnosis, survivorship,

149 herence to the American Cancer Society (ACS) cancer prevention guidelines is associated with a reduct

150 Conventional cancer prevention has primarily focused on single chemop

151 ons, the mechanisms linking COX blockade and cancer prevention have long been an area of active inves

152 ials that have led to licensure for cervical cancer prevention have used the disease endpoint of cerv

153 abstracted from the American Cancer Society Cancer Prevention II Study cohort, with baseline ascerta

154 immune systems are considered important for cancer prevention, immunosurveillance, and control of ca

155 bservation that NSAIDs are most effective in cancer prevention in APC(min/+) mice if the mice are tre

156 istance to cancer may lead to new methods of cancer prevention in humans.

157 el, supporting its further consideration for cancer prevention in LFS patients.

158 formin, a first-line diabetes drug linked to cancer prevention in retrospective clinical analyses, in

159 ld therefore be a strong candidate for liver cancer prevention in the context of aberrant Smad3 signa

160 the substantial importance of DNA repair in cancer prevention in the general population.

161 upplements are not currently recommended for cancer prevention in the general population.

162 t is important to identify obstacles in skin cancer prevention in these communities.

163 ovide a unique prophylactic therapy for skin cancer prevention in XP-C patients.

164 tobacco smoke-constituent biomarkers in lung cancer prevention, including improved lung cancer risk a

165 es of nutrients often suggested for prostate cancer prevention, including lycopene, long-chain n-3 fa

166 d from 51 hospitals into the Ohio Colorectal Cancer Prevention Initiative from January 1, 2013, to Ju

167 ing basic, translational, epidemiologic, and cancer prevention initiatives.

168 ogenesis mechanisms and provided a basis for cancer prevention initiatives.

169 d Hispanics are particularly in need of skin cancer prevention interventions.

170 Reluctance to incorporate cancer prevention into an oncology career seems to stem

171 Therapeutic cancer prevention is a developing area that can gain a l

172 Effective cancer prevention is based on accurate molecular diagnos

173 vidence comparing ICR to CCR with respect to cancer prevention is controversial and inconclusive.

174 The role of vitamin D in breast cancer prevention is equivocal.

175 Low-dose aspirin for cancer prevention is often cited as the most important a

176 Cancer prevention is predicted to result in more positiv

177 However, aspirin's role in cancer prevention is still emerging, and no groups curre

178 The major goal of breast cancer prevention is to reduce the incidence of ductal c

179 Following the lifestyle guidelines for cancer prevention may improve HRQOL among elderly female

180 herence to the WCRF/AICR recommendations for cancer prevention may lower the risk of developing most

181 These findings could be used to target lung-cancer prevention measures to high-risk groups.

182 tion to tamoxifen and raloxifene as a breast cancer prevention medication, although exemestane is not

183 t cancer of 1.66% or greater, discuss breast cancer prevention medications with their primary care pr

184 d provide incentive for reducing weight as a cancer prevention method in overweight and obese individ

185 pants were recruited through the multicenter Cancer Prevention Network and randomly assigned to group

186 Cancer prevention occurs by arresting, slowing down, or

187 sta Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Cent

188 physical activity, and weight management for cancer prevention on the basis of the most comprehensive

189 physical activity, and weight management for cancer prevention on the basis of the most comprehensive

190 atase inhibitors to antiestrogens for breast cancer prevention.Oncogene advance online publication, 2

191 lation of promoter CpG islands may offer new cancer prevention or therapeutic approaches.

192 sent a novel therapeutic approach for breast cancer prevention or treatment based on its pharmacologi

193 dulation of selective sirtuin members to aid cancer prevention or treatment under defined conditions.

194 ons in developing a new metabolic diagram of cancer prevention or treatment.

195 have been conducted in the field of prostate cancer prevention over the past decade.

196 cal Adjuvant Breast and Bowel Project Breast Cancer Prevention P-1), MA.17, and BIG 1-98 (Breast Inte

197 pplements should not be recommended for lung cancer prevention, particularly among smokers.

198 ic evaluation at a time when global cervical cancer prevention policy continues to evolve and evidenc

199 tudy uncover a potential target for cervical cancer prevention, provide insight into the risk assessm

200 tudy was to examine whether adherence to the cancer prevention recommendations of the World Cancer Re

201 nes encourage cancer survivors to follow its cancer prevention recommendations.

202 Skin cancer prevention remains a national priority.

203 eve maximal target tissue effects for breast cancer prevention remains undefined.

204 Cancer Prevention Research Institute of Texas, Red and C

205 These results are important for strategizing cancer prevention, research and public health.

206 ng who we are and what we want to achieve as cancer prevention researchers and practitioners.

207 that are central to the state-of-the-art of cancer prevention science.

208 with the potential to accelerate advances in cancer prevention, screening, and early detection across

209 recommendation for green tea consumption for cancer prevention should be made.

210 ies, such as anti-oestrogen drugs for breast cancer prevention, should be targeted to high-risk group

211 explore known and potential various types of cancer prevention strategies and focus on nonvaccine-bas

212 dominally obese individuals may be important cancer prevention strategies as well as adjuvant therapi

213 pulations may facilitate targeted colorectal cancer prevention strategies.

214 avenue to explore further in the search for cancer-prevention strategies.

215 Such cancer prevention strategy may be critical for high-risk

216 ,843) in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort.

217 s within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort.

218 y mortality from the American Cancer Society Cancer Prevention Study II (ACS CPS-II) cohort have been

219 residence of 668,629 American Cancer Society Cancer Prevention Study II (CPS-II) cohort participants

220 te cancer mortality among 363,726 men in the Cancer Prevention Study II (CPS-II) cohort, of whom 7,45

221 249 postmenopausal, cancer-free women in the Cancer Prevention Study II (CPS-II) Nutrition Cohort, en

222 cer among 43,512 men and 56,011 women in the Cancer Prevention Study II (CPS-II) Nutrition Cohort; 10

223 centrations and lung cancer mortality in the Cancer Prevention Study II (CPS-II), a large prospective

224 r pollution with nonlung cancer death in the Cancer Prevention Study II (CPS-II).

225 articipants from the American Cancer Society Cancer Prevention Study II cohort were linked to modeled

226 bestos-exposed blue collar male workers from Cancer Prevention Study II for whom occupational and smo

227 y the American Cancer Society as part of the Cancer Prevention Study II in 1982.

228 ofessionals Follow-up Study (1986-2004), the Cancer Prevention Study II Nutrition Cohort (1992-2004),

229 ort studies: (1) the American Cancer Society Cancer Prevention Study II Nutrition Cohort and (2) the

230 The Cancer Prevention Study II Nutrition Cohort collected in

231 cipants (60,059 men and 73,196 women) in the Cancer Prevention Study II Nutrition Cohort during the p

232 ned among 55,983 men and 66,655 women in the Cancer Prevention Study II Nutrition Cohort from 1992 to

233 62,792 men and 69,520 women enrolled in the Cancer Prevention Study II Nutrition Cohort in 1992, we

234 The Cancer Prevention Study II Nutrition Cohort is a prospec

235 ta-Carotene Cancer Prevention Study, and the Cancer Prevention Study II Nutrition Cohort to investiga

236 ake with risk of NHL and NHL subtypes in the Cancer Prevention Study II Nutrition Cohort, a prospecti

237 es of Health-AARP Diet and Health Study, the Cancer Prevention Study II Nutrition Cohort, the Health

238 n Retired Persons Diet and Health Study, the Cancer Prevention Study II Nutrition Cohort, the Multiet

239 A total of 132,823 participants in the Cancer Prevention Study II Nutrition Cohort, who were fo

240 estigated their associations with CRC in the Cancer Prevention Study II Nutrition Cohort.

241 tmenopausal breast cancer among women in the Cancer Prevention Study II Nutrition Cohort.

242 Cancer Prevention Study II participants were enrolled in

243 study cohort of the American Cancer Society Cancer Prevention Study II were correlated with air-poll

244 ditive scale between these risk factors from Cancer Prevention Study II, a large prospective US cohor

245 ake with fatal oral/pharyngeal cancer in the Cancer Prevention Study II, a prospective US cohort stud

246 rt study of 499,356 male participants in the Cancer Prevention Study II.

247 The Korean Cancer Prevention Study is a cohort study of South Korea

248 trols in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study of Finnish men.

249 e within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a cohort study of Finnish male

250 Within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a randomized controlled trial c

251 g Trial, the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, and the Cancer Prevention Study

252 and women from 23 states who enrolled in the Cancer Prevention Study-3 cohort during 2006-2009 and ha

253 (random sub-cohort N=1,685) from the Korean Cancer Prevention Study-II (KCPS-II) (N=145,842) was use

254 established in the American Cancer Society's Cancer Prevention Study-II cohort.

255 Cancer Prevention Study-II Nutrition Cohort participants

256 r rectal cancer between 1992 and 2007 in the Cancer Prevention Study-II Nutrition Cohort, a prospecti

257 women and men in the American Cancer Society Cancer Prevention Study-II Nutrition Cohort.

258 Among 138,003 Cancer Prevention Study-II participants, 2,532 incident

259 s been recognized as an important target for cancer prevention, the mechanism by which energy restric

260 ce that prebiotics play a role in colorectal cancer prevention, their role of satiety and weight mana

261 vital role in normal homeostatic control and cancer prevention, they also strongly encourage the emer

262 ed treatment through the Breast and Cervical Cancer Prevention Treatment Program (BCCTP).

263 regulation of the pathway might be useful in cancer prevention, treatment, and regenerative medicine

264 baseline in the placebo arm of the Prostate Cancer Prevention Trial (1993-2003).

265 bo-arm participants enrolled in the Prostate Cancer Prevention Trial (1993-2003).

266 ng data from the placebo arm of the Prostate Cancer Prevention Trial (1993-2003).

267 o participated in the Selenium and Vitamin E Cancer Prevention Trial (2001-2011) with present analyse

268 Using data from the Prostate Cancer Prevention Trial (n = 5,986), we evaluated prosta

269 Reanalysis of the Prostate Cancer Prevention Trial (PCPT) suggests that high-grade

270 In the Prostate Cancer Prevention Trial (PCPT), finasteride significantl

271 tive randomized trials, such as the Prostate Cancer Prevention Trial (PCPT), Reduction by Dutasteride

272 The Selenium and Vitamin E Cancer Prevention Trial (SELECT) and the Physician's Hea

273 The Selenium and Vitamin E Cancer Prevention Trial (SELECT) Eye Endpoints Study was

274 initial report of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) found no reduction in r

275 from the large-scale Selenium and Vitamin E Cancer Prevention Trial (SELECT) showed that antioxidant

276 te cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) through unknown mechani

277 was ancillary to the Selenium and Vitamin E Cancer Prevention Trial (SELECT), a randomized clinical

278 s (REDUCE) trial, and Selenium and Vitamin E Cancer Prevention Trial (SELECT), have provided practiti

279 rostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT), plays an integral role

280 cer among 9,559 participants in the Prostate Cancer Prevention Trial (United States and Canada, 1994-

281 prostate cancer prevention trials (Prostate Cancer Prevention Trial [PCPT] and Selenium and Vitamin

282 tion Trial [PCPT] and Selenium and Vitamin E Cancer Prevention Trial [SELECT]) were examined to defin

283 R (Study of Tamoxifen and Raloxifene) breast cancer prevention trial and in other clinical trials.

284 ticipants, aged 55-84 years, in the Prostate Cancer Prevention Trial during 1994-2003.

285 Another large, Phase III prostate cancer prevention trial showed no benefit for either sel

286 IENTS AND METHODS Raw data from the Prostate Cancer Prevention Trial were used to model chemopreventi

287 carriers leading to an international breast cancer prevention trial, and insights into the intricate

288 ifen were estimated from STAR and the Breast Cancer Prevention Trial.

289 thin the Mammary Prevention.3 (MAP.3) breast cancer prevention trial.

290 d, double-blind, placebo-controlled, primary cancer prevention trial; participants were Finnish male

291 from the placebo arms of two large prostate cancer prevention trials (Prostate Cancer Prevention Tri

292 large, population-based, Phase III prostate cancer prevention trials have shown a significant benefi

293 nly used to determine eligibility for breast cancer prevention trials was greatly increased relative

294 sion Among screened men enrolled in prostate cancer prevention trials, differences in risk factor est

295 ys essential roles in organ size control and cancer prevention via restricting its downstream effecto

296 Screening detection, rather than long-term cancer prevention, was evaluated.

297 Considering these roles and cancer prevention, we hypothesized that tumor CTNNB1 sta

298 ns and Relevance: Important barriers to skin cancer prevention were lack of knowledge, the belief tha

299 plant-based foods seem promising for stomach cancer prevention, while vitamin C lowers the risk of es

300 t to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeut

301 ost $2.9 billion over 10 years; savings from cancer prevention would be realized decades later.